Inventor · disambiguated record
Jeremy Bastid
Also filed as: BASTID JEREMY · BASTID JÉRÉMY
3 granted patents·10 pending applications·5 citations·filing 2011–2021
60Inventor score
Files withOREGA BIOTECH8BASTID JEREMY1BENSUSSAN ARMAND1INNATE PHARMA1INSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE1
Top patents by PatentIndex Score
13 records- 0176US10351623B2Antagonists of IL-17 isoforms and their usesOREGA BIOTECH·Filed 2017·Granted Jul 16, 2019·3 cites·11 claims
- 0265US9676847B2IL-17 antagonist antibodiesOREGA BIOTECH·Filed 2013·Granted Jun 13, 2017·1 cites·33 claims
- 0364US9834601B2Antagonists of IL-17 isoforms and their usesOREGA BIOTECH·Filed 2013·Granted Dec 5, 2017·1 cites·6 claims
- 0455US2021261686A1Antibodies against human cd39 and use thereofOREGA BIOTECH·Filed 2020·Application pending·0 cites
- 0552US2017233468A1Il-17 antagonist antibodiesOREGA BIOTECH·Filed 2017·Application pending·0 cites
- 0647US2023045494A1Combination therapies based on ctla4 and il-17b inhibitorsOREGA BIOTECH·Filed 2021·Application pending·0 cites
- 0745US2022281967A1Novel il-17b antibodiesOREGA BIOTECH·Filed 2020·Application pending·0 cites
- 0842US2022175815A1Combination therapies based on pd1 and il-17b inhibitorsOREGA BIOTECH·Filed 2020·Application pending·0 cites
- 0941US2014023650A1Methods of Treating and/or Preventing Cell Proliferation Disorders with IL-17 AntagonistsINST MEDICAL DE LA SANTE ET DE LA RECH MEDICALE·Filed 2013·Application pending·0 cites
- 1041US2013273062A1Antibodies against human cd39 and use thereofBENSUSSAN ARMAND·Filed 2011·Application pending·0 cites
- 1138US2019153113A1Cd39 vascular isoform targeting agentsINNATE PHARMA·Filed 2016·Application pending·0 cites
- 1236US2011293629A1Methods of Treating and/or Preventing Cell Proliferation Disorders with IL-17 AntagonistsBASTID JEREMY·Filed 2011·Application pending·0 cites
- 1330US2019151346A1Combinations therapies for the treatment of cancerINSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →